Ticker Scorecard - ANAB Basics Company: AnaptysBio, Inc. IPO Date: January 26, 2017 Sector: Healthcare Industry: Biotech Market Cap: $538.82M Activated in VL: True Average Daily Range Avg Daily Range: $0.97 | 2.64% Avg Daily Range (30 D): $0.87 | 5.30% Avg Daily Range (90 D): $0.73 | 4.11% Institutional Daily Volume Avg Daily Volume: .29M Avg Daily Volume (30 D): 1.02M Avg Daily Volume (90 D): .72M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 84 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 2,748 Avg Inst. Trade: $1.69M Avg Inst. Trade (30 D): $1.51M Avg Inst. Trade (90 D): $1.48M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $1.77M Avg Closing Trade (90 D): $1.49M Avg Closing Volume: 50.34K     News Aug 23, 2024 @ 11:26 AM Why AnaptysBio Was Such a Healthy Stock This Week Source: Eric Volkman Aug 14, 2024 @ 9:00 AM Anaptys Announces Pricing of $100 Million Underwri... Source: N/A Jun 24, 2024 @ 11:33 AM Repligen (RGEN) Soars 4.4%: Is Further Upside Left... Source: Zacks Equity Research May 10, 2024 @ 9:01 PM The Analyst Landscape: 7 Takes On AnaptysBio Source: Benzinga Insights May 9, 2024 @ 9:45 PM AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-6.05 $-1.14 $-1.71 Diluted EPS $-6.05 $-1.14 $-1.71 Revenue $ 57.17M $ 30.02M $ 10.97M Gross Profit $ $ $ Net Income / Loss $ -165.66M $ -32.85M $ -46.66M Operating Income / Loss $ -147.41M $ -22.76M $ -40.32M Cost of Revenue $ $ $ Net Cash Flow $ 165.29M $ 119.76M $ 18.13M PE Ratio